Other Resources and Information
From ISMP/ECRI:
-
[Spreadsheet] Tracking future availability of drugs that might be going into shortage | Forecasting how many days of drug may be left with current usage rates, inventory, and rate of change [Courtesy of Michael Van Ornum- Sentara Martha Jefferson Hospital]
- [Resource] Comments from March 2020 MSOS Member Briefing Q&A on COVID-19
-
[Article] General advice on medication safety issues caused by shortages
-
[Article] Anticipated infusion pump/dedicated administration set shortages
-
[Webinar] ISMP-ECRI webinar on infusion therapy and conserving supplies in age of COVID-19
-
[Online Forum] Medication Safety Officers Society (MSOS) discussion board on current issues
-
[Webinar] Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States?
-
[Webinar] Prevention of Drug Diversion in the Healthcare Setting
-
[Webinar] Medication Safety During COVID-19: What Have We Learned
-
[Webinar] Managing Infusion in the Age of COVID-19
External Sources:
-
FDA | Regeneron monoclonal antibodies (casirivimab and imdevimab) EUA for healthcare providers
-
FDA | Regeneron monoclonal antibodies (casirivimab and imdevimab) EUA for patients, parents and caregivers
-
ASHP | Assessment of Evidence for COVID-19 Related Treatments
-
AHA Journal | Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates with Suspected or Confirmed COVID-19
-
IDSA | Guidelines on the Treatment and Management of Patients with COVID-19
-
AIHA | Proper Use of Masks for Healthcare Workers and First Responders
-
B. Braun | Gravity Flow Chart
-
Medscape | In Memoriam: Healthcare Workers Who Have Died of COVID-19
-
National Institute for Occupational Safety and Health (NIOSH) | Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators
-
US Environmental Protection Agency (EPA) | Disinfectants for Use Against SARS-CoV-2
-
US Food and Drug Administration (FDA) | Enforcement Policy for Infusion Pumps and Accessories During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
-
USP | USP Considerations for Sterile Compounding during COVID-19 Pandemic (Addresses Beyond Use Dating)
-
ASHP | ASHP/ University of Utah Drug Information Service list of current drugs in shortage
-
FDA | FDA drug shortage index